[1] Almeida CERD, Figueiredo EG, Monaco BAD, et al. Neurogenic pulmonary edema[J]. JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA, 2018, 21(1):49-52. DOI:10.22290/jbnc.v21i1.817.
[2] 李春林.动脉瘤介入栓塞术与颅内动脉瘤夹闭术治疗高分级动脉瘤性蛛网膜下腔出血的临床效果[J].慢性病学杂志,2022,23(11):1654-1656,1660. DOI:10.16440/J.CNKI.1674-8166.2022.11.14.
[3] Veeravagu A, Chen YR, Ludwig C, et al. Acute lung injury in patients with subarachnoid hemorrhage: a nationwide inpatient sample study[J]. World Neurosurg, 2014, 82(1-2):e235- e241. DOI: 10.1016/j.wneu.2014.02.030.
[4] 朱君孺,陈宏山.CTA与DSA在颅内动脉瘤诊断中的对比研究[J].中国CT和MRI杂志,2022,20(5):43-45. DOI:10.3969/j.issn.1672-5131.2022.05.015.
[5] Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group[J]. Stroke, 2010, 41(10):2391-2395. DOI: 10.1161/STROKEAHA.110.589275.
[6] 陈蓦,王武.颅内动脉瘤血管内治疗现状与进展[J].介入放射学杂志,2018,27(6):592-597. DOI:10.3969/j.issn.1008- 794X.2018.06.023.
[7] 张延迪,郭莹莹.基于循证理论的预见性护理干预对颅内动脉瘤介入治疗术后患者的影响[J].国际医药卫生导报,2023,29(3):395-399. DOI:10.3760/cma.j.issn.1007-1245. 2023.03.022.
[8] 赵贞贞.盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果[J].国际医药卫生导报,2022,28(6):765-768. DOI:10.3760/cma.j.issn.1007-1245.2022.06.008.
[9] 谢延琼,陈晓林,李锋,等.瑞芬太尼用于经DSA颅内动脉瘤栓塞术麻醉效果分析[J].当代医学,2019,25(11):148-150. DOI:10.3969/j.issn.1009-4393.2019.11.067.
[10] Sluzewski M, Bosch JA, van Rooij WJ, et al. Rupture of intracranial aneurysms during treatment with Guglielmi detachable coils: incidence, outcome, and risk factors[J]. J Neurosurg, 2001, 94(2):238-240. DOI: 10.3171/jns.2001.94.2.0238.
[11] 赵开胜,杨延庆,刘赟.脑出血昏迷患者神经源性肺水肿的治疗[J].基础医学与临床,2018,38(11):1563-1567. DOI:10.3969/j.issn.1001-6325.2018.11.012.
[12] 谢思宁,吴震.神经源性肺水肿的研究现状[J].临床神经外科杂志,2018,15(2):158-160. DOI:10.3969/j.issn.1672- 7770.2018.02.019.
[13] 邵喜娜,周婷.颅内动脉瘤血管内介入栓塞术病人疾病不确定感的影响因素及护理对策[J].全科护理,2022,20(26):3688-3692. DOI:10.12104/j.issn.1674-4748.2022.26.023.
[14] 曾以勒.不同位置动脉瘤破裂所致迟发性脑缺血的空间分布研究[J].国际医药卫生导报,2022,28(21):3072-3076. DOI:10.3760/cma.j.issn.1007-1245.2022.21.023.
[15] 嵇鹏.早期机械通气对重型颅脑损伤并神经源性肺水肿的临床疗效分析[J/CD].现代医学与健康研究(电子版),2019,3(13):77-78.
[16] 杜绍楠,刘志.脑出血后神经源性肺水肿的相关因素分析[J].中国医科大学学报,2018,47(3):256-259. DOI:10.12007/j.issn.0258-4646.2018.03.015.
[17] 杨全喜,李家亮,苗鹏飞,等.持续腰大池引流配合超早期显微手术治疗颅内动脉瘤破裂的临床效果[J].临床医学,2022,42(11):24-26. DOI:10.19528/j.issn.1003-3548. 2022.11.008.
[18] 王娟,艾娜,董欣.以患者结局为导向的强化护理对颅内动脉瘤介入术后患者的应用效果[J].中国肿瘤临床与康复,2022,29(8):990-994. DOI:10.13455/j.cnki.cjcor.2022. 08.24.
[19] 陈红,吴键,张晋珍,等.医护一体化结合快速康复外科模式在脑动脉瘤介入栓塞治疗中护理干预效果[J].昆明医科大学学报,2022,43(4):163-169. DOI:10.12259/j.issn.2095- 610X.S20220431.
[20] 陈美娜.颅内动脉瘤介入治疗的围手术期护理[J].中国医药指南,2018,16(2):255-256. DOI: 10.15912/j.cnki.gocm. 2018.02.216.
[21] 杨劲,周怡兴.影响动脉瘤性蛛网膜下腔出血预后因素研究进展[J].现代医院,2021,21(8):1297-1300. DOI:10.3969/j.issn.1671-332X.2021.08.044.
[22] Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage[J]. J Neurosurg Anesthesiol, 2008, 20(3):188-192. DOI: 10.1097/ANA.0b013e3181778156.
[23] 宋加友,刘秀广,王燕飞,等.颅脑损伤患者细胞因子水平变化与神经源性肺水肿发生的关系[J].山东医学高等专科学校学报,2020,42(2):85-87. DOI:10.3969/j.issn.1674-0947. 2020.02.003.
[24] 杨磊,张栋梁,韩永丰,等.高分级动脉瘤性蛛网膜下腔出血患者血miRNA155水平预测神经源性肺水肿发生的研究[J].河北医科大学学报,2018,39(5):543-546,551. DOI:10.3969/j.issn.1007-3205.2018.05.011.
[25] Hamdy O, Maekawa H, Shimada Y, et al. Role of central nervous system nitric oxide in the development of neurogenic pulmonary edema in rats[J]. Crit Care Med, 2001, 29(6):1222-1228. DOI: 10.1097/00003246- 200106000-00028.
|